Mercury Laboratories informs about change in management

14 Jun 2024 Evaluate
Pursuant to Regulation 30 read with Para A (7) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Mercury Laboratories has informed that Jagdish Patil has been appointed as Head of the Department (Dept.-Injectable Production) of the Company with effect from June 14, 2024. The details of changes as required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with Section V-A of Chapter V of Master Circular issued vide circular no. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 and SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Mercury Laboratories Share Price

819.05 0.00 (0.00%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...